Latest news and research on all cancers and treatments, updated several times a week
... HyperAcute Pancreas immunotherapy that is being studied in Phase III clinical trials in surgically-resected pancreatic cancer patients, as well as in ...
By type, the incidence rates for gastric, colorectal, liver, lung and cervical cancer dropped, but those for breast, pancreatic, renal and thyroid cancer ...
Both drugs target a protein called PD-1, a molecular brake that prevents the immune system from seeing tumors as invaders and enables cancer to ...
Theralase Technologies (TSX: V.TLT, Stock Forum) had reason to break out the champagne today when the company announced preliminary results ...
... T393C polymorphism and prognosis in several types of cancer, including breast carcinoma, squamous cell carcinoma of the larynx, bladder cancer, ...
Therapeutic decisions for muscle-invasive bladder cancer (MIBC) are largely based on histopathologic characteristics. In this issue of Cancer Cell, ...
Mistletoe extracts have also been used in cancer immunotherapy in Austria, Germany, and Switzerland (3). The field of immunotherapy, particularly ...
In the latest study on dietary patterns and breast cancer risk, healthier ... pancreatic cancer, lung cancer, oral and throat cancers, esophageal cancer, ...
Cancer News in Science Daily
Key events that prompt certain cancer cells to develop resistance to otherwise lethal therapies have been identified by researchers. By mapping the specific steps that cells of melanoma, breast cancer and a blood cancer called myelofibrosis use to become resistant to drugs, the researchers now have much better targets for blocking those pathways and keeping current therapies effective.
For the first time, mutations that destabilize a DNA structure that turns a gene off have been discovered by researchers. The mutations occur at four sites in the hTERT promoter in more than 75 percent of glioblastomas and melanomas.
To examine internal organs, doctors often use a tube with light and a tiny camera attached to it. The device, called an endoscope, helps detect cancer and other illnesses. It may soon serve another purpose: zapping tumors. The biomedical advancement, which is under development, could make chemotherapy more efficient, reduce its side effects and improve how doctors treat some of the most deadly forms of cancer.
Tambahkan Komentar